Kayne Anderson Rudnick Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21
Closed -$325 1106
2025
Q2
$325 Hold
21
﹤0.01% 1027
2025
Q1
$312 Hold
21
﹤0.01% 926
2024
Q4
$278 Sell
21
-88
-81% -$1.21K ﹤0.01% 963
2024
Q3
$1.55K Sell
109
-585,734
-100% -$8.31M ﹤0.01% 840
2024
Q2
$7.58M Sell
585,843
-14,069
-2% -$186K 0.02% 258
2024
Q1
$8.33M Buy
599,912
+1,788
+0.3% +$26K 0.02% 257
2023
Q4
$8.54M Buy
598,124
+140,463
+31% +$1.99M 0.02% 258
2023
Q3
$7.08M Sell
457,661
-22,427
-5% -$347K 0.02% 270
2023
Q2
$7.54M Buy
480,088
+6,809
+1% +$112K 0.02% 269
2023
Q1
$7.8M Buy
+473,279
New +$7.54M 0.02% 263
2022
Q2
Sell
-108
Closed -$2K 680
2022
Q1
$2K Buy
+108
New +$1.59K ﹤0.01% 605

Other funds holding TAK